A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species von Uechi, Kohei, Tada, Tatsuya, Shimada, Kayo, Kuwahara-Arai, Kyoko, Arakaki, Momoko, Tome, Takaaki, Nakasone, Isamu, Maeda, Shiro, Kirikae, Teruo, Fujita, Jiro

Volltext

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy von Watanabe, Sho, Shimoi, Tatsunori, Nishikawa, Tadaaki, Kawachi, Asuka, Okuma, Hitomi Sumiyoshi, Tokura, Momoko, Yazaki, Shu, Mizoguchi, Chiharu, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Kojima, Yuki, Sudo, Kazuki, Noguchi, Emi, Yoshida, Akihiko, Kawai, Akira, Fujiwara, Yasuhiro, Yonemori, Kan

Volltext

Connexin 43 Is Necessary for Salivary Gland Branching Morphogenesis and FGF10-induced ERK1/2 Phosphorylation von Yamada, Aya, Futagi, Masaharu, Fukumoto, Emiko, Saito, Kan, Yoshizaki, Keigo, Ishikawa, Masaki, Arakaki, Makiko, Hino, Ryoko, Sugawara, Yu, Ishikawa, Momoko, Naruse, Masahiro, Miyazaki, Kanako, Nakamura, Takashi, Fukumoto, Satoshi

Volltext

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer von Sanomachi, Tomomi, Okuma, Hitomi Sumiyoshi, Kitadai, Rui, Kawachi, Asuka, Yazaki, Shu, Tokura, Momoko, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimoi, Tatsunori, Noguchi, Emi, Fujiwara, Yasuhiro, Sugino, Hirokazu, Shiino, Sho, Suto, Akihiko, Yoshida, Masayuki, Yonemori, Kan

Volltext

MO41-6 Trastuzumab-deruxtecan and blood inflammatory markers in HER2-positive metastatic breast cancer von Onishi, Mai, Shimoi, Tatsunori, Kitadai, Rui, Tokura, Momoko, Yazaki, Shu, Sumiyoshi-Okuma, Hitomi, Arakaki, Motoko, Saito, Ayumi, Kita, Syosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Noguchi, Emi, Fujiwara, Yasuhiro, Yonemori, Kan

Volltext

MO9-1 Clinical characteristics of HER2-low stage I triple-negative breast cancer von Sanomachi, Tomomi, Shumiyoshi, Hitomi Okuma, Kitadai, Rui, Kawachi, Asuka, Yazaki, Shu, Tokura, Momoko, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimoi, Tatsunori, Noguchi, Emi, Fujiwara, Yasuhiro, Suto, Akihiko, Yonemori, Kan

Volltext

MO42-6 Analysis of sperm preservation in patients with mediastinal germ cell tumor patients von Umamoto, Kotaro, Saito, Ayumi, Noguchi, Emi, Takahashi, Yoshiko, Kitadai, Rui, Arakaki, Motoko, Yazaki, Shu, Tokura, Momoko, Kawachi, Asuka, Yamamoto, Kasumi, Kita, Shosuke, Kojima, Yuki, Maejima, Aiko, Nakamura, Eijiro, Nishikwa, Tadaaki, Shimoi, Tatsunori, Sudo, Kazuki, Yonemori, Kan

Volltext

MO33-2 Retrospective analysis of urothelial carcinoma treated with enfortumab vedotin at our institution von Imai, Toru, Kita, Shosuke, Shimoi, Tatsunori, Yazaki, Shu, Tokura, Momoko, Kawachi, Asuka, Okuma, Hitomi S., Nakamura, Eijiro, Arakaki, Motoko, Saito, Ayumi, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Noguchi, Emi, Matsui, Yoshiyuki, Fujiwara, Yasuhiro, Yonemori, Kan

Volltext

MO17-1 Clinical practice of comprehensive genomic profiling in gynecologic malignancies at National Cancer Center Hospital von Chiba, Yohei, Sudo, Kazuki, Arakaki, Motoko, Saito, Ayumi, Tokura, Momoko, Yazaki, Syu, Mizoguchi, Chiharu, Okuma, Hitomi, Kita, Syosuke, Yamamoto, Kasumi, Kojima, Yuki, Nishikawa, Tadaaki, Noguchi, Emi, Shimoi, Tatsunori, Yonemori, Kan

Volltext

P38-3 Clinical outcomes of next-generation sequencing test for breast cancer at the National Cancer Center Hospital von Nishimura, Rumi, Kazuki, Sudo, Arakaki, Motoko, Saitou, Ayumi, Chiba, Yohei, Tokura, Momoko, Mizoguchi, Chiharu, Kita, Shousuke, Yamamoto, Kasumi, Yazaki, Shu, Okuma, Hitomi, Kojima, Yuki, Nishikawa, Tadaaki, Noguchi, Emi, Shimoi, Tatsunori, Yonemori, Kan

Volltext